← Back to Clinical Trials
Recruiting NCT06871995

NCT06871995 Efficacy, Safety and Limitations of Spinal Block for All Infants Under 3 Months

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06871995
Status Recruiting
Phase
Sponsor Ain Shams University
Condition Anesthesia
Study Type INTERVENTIONAL
Enrollment 90 participants
Start Date 2025-03
Primary Completion 2025-06

Eligibility & Interventions

Sex All sexes
Min Age 1 Day
Max Age 3 Months
Study Type INTERVENTIONAL
Interventions
spinal block

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 90 participants in total. It began in 2025-03 with a primary completion date of 2025-06.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Spinal anesthesia (SA) has been shown to be a viable alternative to general anesthesia (GA) for infants and children for a variety of surgical procedures. SA serves to avoid some of the potential risks of GA including the need for airway manipulation, hemodynamic instability, postoperative apnea, and exposure to medications that may cause neurotoxicity .SA allows the prevention and reduction of perioperative complications even if its duration is an important limiting factor. Because of this limitation, short surgery is the most indicated under SA . Premature infants and neurologically impaired children account for the majority of spinal anesthetics used today . This study evaluates the effectiveness, safety and limitations of spinal anesthesia when used for all infants under 3 months undergoing lower abdominal surgery at Ain Shams University Hospitals.

Eligibility Criteria

Inclusion Criteria * Age under 3 months. * Physical status: American Society of Anesthesiologists I - II. * Elective lower abdominal surgeries such as: hernia, hydrocele, undescended testis Exclusion Criteria: * Patient's parents or legal guardian refusing to do this specific procedure. * Coagulopathy, use of anti-coagulant or antiplatelet therapy. * Infection at the site of injection.

Contact & Investigator

Central Contact

ahmed ma Elewa mohamed, M.S.C

✉ AhmedElfax@med.asu.edu.eg

📞 +201028143995

Principal Investigator

hany mo Elzahaby, prof

STUDY DIRECTOR

Ain Shams University

Frequently Asked Questions

Who can join the NCT06871995 clinical trial?

This trial is open to participants of all sexes, aged 1 Day or older, up to 3 Months, studying Anesthesia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06871995 currently recruiting?

Yes, NCT06871995 is actively recruiting participants. Contact the research team at AhmedElfax@med.asu.edu.eg for enrollment information.

Where is the NCT06871995 trial being conducted?

This trial is being conducted at Cairo, Egypt.

Who is sponsoring the NCT06871995 clinical trial?

NCT06871995 is sponsored by Ain Shams University. The principal investigator is hany mo Elzahaby, prof at Ain Shams University. The trial plans to enroll 90 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology